Multiple sclerosis (MS) needs regular monitoring even when a person feels well. Doctors monitor MS to answer three important questions:
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
- Is the disease still active?
- Is disability changing over time?
- Is the current treatment working safely?
Monitoring usually combines clinical appointments, neurological examination, MRI scans and treatment-specific blood or other safety tests.
For a broader overview of diagnosis and available therapies, see our main guide to Multiple Sclerosis (MS) Treatment.
What Tests Are Used to Monitor MS?
| Monitoring Method | What It Checks |
|---|---|
| Clinical review | Relapses, new symptoms and disease progression |
| Neurological examination | Strength, sensation, balance, vision, coordination and other neurological functions |
| MRI scan | New or enlarging MS lesions and inflammatory activity |
| Disability assessment | Changes in walking, hand function and independence |
| Blood and other safety tests | Side effects and risks related to disease-modifying treatment |
| Symptom review | Fatigue, pain, bladder problems, cognition, mood and daily function |
1. Regular MS Check-Ups
Regular appointments with a neurologist or MS team are a central part of monitoring. Current NICE guidance recommends that people with MS receive a comprehensive review at least once every year, although some patients need more frequent appointments depending on their disease and treatment.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
During a review, the clinician may ask about:
- Any relapses since the last appointment
- New neurological symptoms
- Gradual worsening of existing symptoms
- Walking and balance
- Falls
- Hand and arm function
- Fatigue
- Pain and spasticity
- Bladder and bowel function
- Vision
- Memory and concentration
2. Neurological Examination
A neurological examination helps doctors compare a person's current function with previous visits. The neurologist may assess:
- Muscle strength
- Reflexes
- Sensation
- Balance
- Coordination
- Walking
- Eye movements and vision
3. MRI Scans
MRI is one of the most important tools for monitoring MS. It can show:
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
- New MS lesions
- Enlarging lesions
- Areas of recent inflammatory activity
- Changes in the brain or spinal cord over time
MRI is particularly useful because MS can sometimes be active without causing obvious symptoms. A person may feel stable while a scan shows new lesions.
How Often Is an MRI Needed?
There is no single MRI schedule for every person with MS. The frequency depends on:
- How active the MS is
- Which treatment is being used
- Whether new symptoms have appeared
- Whether doctors are considering changing treatment
After starting a disease-modifying therapy, some MS services perform a follow-up MRI after approximately 3 to 6 months to establish a new treatment baseline. Further MRI scans are then performed periodically, with the interval individualised by the MS team.
4. Monitoring Relapses
Doctors keep track of both the number and severity of MS relapses. Important questions include:
- How many relapses occurred?
- How severe were they?
- Did the person recover completely?
- Did the relapse leave new disability?
A new relapse while taking a disease-modifying therapy does not automatically mean treatment has failed. However, repeated relapses combined with new MRI activity may indicate that the current treatment is not controlling MS sufficiently.
5. Monitoring Disability and Daily Function
MS monitoring is not limited to counting lesions on an MRI. Doctors also assess whether a person's ability to function is changing. This may include:
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
- Walking distance and speed
- Balance
- Ability to use the hands
- Need for walking aids
- Ability to work or perform everyday activities
Measures such as the Expanded Disability Status Scale (EDSS) may be used to document neurological disability over time. The important point is that MRI and physical function need to be interpreted together.
6. Blood Tests During MS Treatment
Many disease-modifying therapies affect the immune system, so monitoring also checks whether treatment remains safe. Depending on the medicine, blood tests may assess:
- Blood-cell counts
- Liver function
- Kidney function when relevant
- Immune-cell levels
- Signs of infection
Some treatments require additional medicine-specific monitoring. The type and frequency of testing therefore depend on the particular DMT being used. Blood tests usually monitor treatment safety rather than directly measuring how active the MS itself is.
7. Monitoring Symptoms That MRI Cannot Fully Measure
An MRI cannot show every way that MS affects daily life. Regular reviews should also assess symptoms such as:
- Fatigue
- Neuropathic pain
- Muscle stiffness and spasms
- Bladder and bowel problems
- Sleep difficulties
- Depression or anxiety
- Memory and concentration problems
How Is Progressive MS Monitored?
Monitoring progressive MS can be different because disability may worsen gradually without obvious relapses. Doctors pay particular attention to changes such as:
- Walking becoming steadily more difficult
- Increasing use of mobility aids
- Declining hand function
- Changes in balance
- Increasing fatigue
- Reduced independence
When Might Treatment Be Changed?
The MS team may reconsider treatment if monitoring shows:
- Repeated relapses
- New or enlarging MRI lesions
- Increasing disability
- Significant treatment side effects
- Safety concerns from blood tests
Sometimes the appropriate response is closer observation. In other situations, switching to a different or higher-efficacy disease-modifying therapy may be considered.
The Bottom Line
Multiple sclerosis is monitored using a combination of clinical reviews, neurological examination, MRI scans, disability assessment and treatment-specific safety tests. Regular MRI scans help identify new inflammatory activity, including lesions that may develop without noticeable symptoms.
Clinical monitoring is equally important because walking, balance, cognition, fatigue and other aspects of daily function may change even when MRI findings appear relatively stable. People taking disease-modifying treatments also need blood or other safety tests according to the specific medicine being used.
Current NICE guidance recommends a comprehensive MS review at least once a year, with more frequent monitoring when disease activity or treatment requires it. The aim of monitoring is not simply to repeat tests—it is to identify disease activity or progression early enough to adjust treatment and protect neurological function whenever possible.
